Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma

Asthma is a chronic respiratory disease affecting people of all ages, especially children, worldwide. Origins of asthma are suggested to be placed in early life with heterogeneous clinical presentation, severity and pathophysiology. Exacerbations of asthma disease can be triggered by many factors, i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Susanne Krammer, Cristina Sicorschi Gutu, Janina C. Grund, Mircea T. Chiriac, Sabine Zirlik, Susetta Finotto
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/6840a7bd45d44656998eeb421323f7f7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6840a7bd45d44656998eeb421323f7f7
record_format dspace
spelling oai:doaj.org-article:6840a7bd45d44656998eeb421323f7f72021-11-10T06:31:06ZRegulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma1664-322410.3389/fimmu.2021.731807https://doaj.org/article/6840a7bd45d44656998eeb421323f7f72021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.731807/fullhttps://doaj.org/toc/1664-3224Asthma is a chronic respiratory disease affecting people of all ages, especially children, worldwide. Origins of asthma are suggested to be placed in early life with heterogeneous clinical presentation, severity and pathophysiology. Exacerbations of asthma disease can be triggered by many factors, including viral respiratory tract infections. Rhinovirus (RV) induced respiratory infections are the predominant cause of the common cold and also play a crucial role in asthma development and exacerbations. Rhinovirus mainly replicates in epithelial cells lining the upper and lower respiratory tract. Type III interferons, also known as interferon-lambda (IFNλ), are potent immune mediators of resolution of infectious diseases but they are known to be involved in autoimmune diseases as well. The protective role of type III IFNs in antiviral, antibacterial, antifungal and antiprotozoal functions is of major importance for our innate immune system. The IFNλ receptor (IFNλR) is expressed in selected types of cells like epithelial cells, thus orchestrating a specific immune response at the site of viruses and bacteria entry into the body. In asthma, IFNλ restricts the development of TH2 cells, which are induced in the airways of asthmatic patients. Several studies described type III IFNs as the predominant type of interferon increased after infection caused by respiratory viruses. It efficiently reduces viral replication, viral spread into the lungs and viral transmission from infected to naive individuals. Several reports showed that bronchial epithelial cells from asthmatic subjects have a deficient response of type III interferon after RV infection ex vivo. Toll like Receptors (TLRs) recognize pathogen-associated molecular patterns (PAMPs) expressed on infectious agents, and induce the development of antiviral and antibacterial immunity. We recently discovered that activation of TLR7/8 resulted in enhanced IFNλ receptor mRNA expression in PBMCs of healthy and asthmatic children, opening new therapeutic frontiers for rhinovirus-induced asthma. This article reviews the recent advances of the literature on the regulated expression of type III Interferons and their receptor in association with rhinovirus infection in asthmatic subjects.Susanne KrammerCristina Sicorschi GutuJanina C. GrundMircea T. ChiriacSabine ZirlikSusetta FinottoFrontiers Media S.A.articleasthmainterferonrhinovirusexacerbationTLR7/8epithelial cellsImmunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic asthma
interferon
rhinovirus
exacerbation
TLR7/8
epithelial cells
Immunologic diseases. Allergy
RC581-607
spellingShingle asthma
interferon
rhinovirus
exacerbation
TLR7/8
epithelial cells
Immunologic diseases. Allergy
RC581-607
Susanne Krammer
Cristina Sicorschi Gutu
Janina C. Grund
Mircea T. Chiriac
Sabine Zirlik
Susetta Finotto
Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma
description Asthma is a chronic respiratory disease affecting people of all ages, especially children, worldwide. Origins of asthma are suggested to be placed in early life with heterogeneous clinical presentation, severity and pathophysiology. Exacerbations of asthma disease can be triggered by many factors, including viral respiratory tract infections. Rhinovirus (RV) induced respiratory infections are the predominant cause of the common cold and also play a crucial role in asthma development and exacerbations. Rhinovirus mainly replicates in epithelial cells lining the upper and lower respiratory tract. Type III interferons, also known as interferon-lambda (IFNλ), are potent immune mediators of resolution of infectious diseases but they are known to be involved in autoimmune diseases as well. The protective role of type III IFNs in antiviral, antibacterial, antifungal and antiprotozoal functions is of major importance for our innate immune system. The IFNλ receptor (IFNλR) is expressed in selected types of cells like epithelial cells, thus orchestrating a specific immune response at the site of viruses and bacteria entry into the body. In asthma, IFNλ restricts the development of TH2 cells, which are induced in the airways of asthmatic patients. Several studies described type III IFNs as the predominant type of interferon increased after infection caused by respiratory viruses. It efficiently reduces viral replication, viral spread into the lungs and viral transmission from infected to naive individuals. Several reports showed that bronchial epithelial cells from asthmatic subjects have a deficient response of type III interferon after RV infection ex vivo. Toll like Receptors (TLRs) recognize pathogen-associated molecular patterns (PAMPs) expressed on infectious agents, and induce the development of antiviral and antibacterial immunity. We recently discovered that activation of TLR7/8 resulted in enhanced IFNλ receptor mRNA expression in PBMCs of healthy and asthmatic children, opening new therapeutic frontiers for rhinovirus-induced asthma. This article reviews the recent advances of the literature on the regulated expression of type III Interferons and their receptor in association with rhinovirus infection in asthmatic subjects.
format article
author Susanne Krammer
Cristina Sicorschi Gutu
Janina C. Grund
Mircea T. Chiriac
Sabine Zirlik
Susetta Finotto
author_facet Susanne Krammer
Cristina Sicorschi Gutu
Janina C. Grund
Mircea T. Chiriac
Sabine Zirlik
Susetta Finotto
author_sort Susanne Krammer
title Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma
title_short Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma
title_full Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma
title_fullStr Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma
title_full_unstemmed Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma
title_sort regulation and function of interferon-lambda (ifnλ) and its receptor in asthma
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/6840a7bd45d44656998eeb421323f7f7
work_keys_str_mv AT susannekrammer regulationandfunctionofinterferonlambdaifnlanditsreceptorinasthma
AT cristinasicorschigutu regulationandfunctionofinterferonlambdaifnlanditsreceptorinasthma
AT janinacgrund regulationandfunctionofinterferonlambdaifnlanditsreceptorinasthma
AT mirceatchiriac regulationandfunctionofinterferonlambdaifnlanditsreceptorinasthma
AT sabinezirlik regulationandfunctionofinterferonlambdaifnlanditsreceptorinasthma
AT susettafinotto regulationandfunctionofinterferonlambdaifnlanditsreceptorinasthma
_version_ 1718440474564362240